Ministerial Ordinance Amending Pharmaceuticals and Medical Devices Act Fee Rules
医薬品、医療機器等の品質、有効性及び安全性の確保等に関する法律等の一部を改正する法律の一部の施行に伴う厚生労働省関係省令の整備等に関する省令
Published: 2026-09-30 · Source: e-Gov Law Search — Updated Laws · Stage: Scheduled to Take Effect · Area: Healthcare / Pharmaceuticals · Impact (preliminary): Medium · First detected by this dashboard: 2026-10-16
View the original Japanese source More Healthcare / Pharmaceuticals updates Search all updates in the dashboard
AI summary
Generated by AI from the Japanese source metadata. It is an unofficial monitoring aid, not legal advice, and may contain errors. The area, stage, and impact labels are preliminary keyword-based triage labels. Confirm every point in the original Japanese source.
Summary
Ministry of Health, Labour and Welfare Ordinance No. 142 of 2026 was promulgated on 2026-09-30, with an effective date of 2027-05-20. It amends the Fee Rules under the Pharmaceuticals and Medical Devices Act (Ministry of Health and Welfare Ordinance No. 63 of 2000) as part of adjustments to ministry ordinances accompanying partial implementation of an Act amending that Act and other laws.
Business Impact
Pharmaceutical and medical device businesses subject to these fee rules may be affected by the amendments, but the listing does not identify the fees or procedures being changed.
Recommended Action
Review of the official Japanese ordinance could clarify the amended fee provisions, their scope and any transitional arrangements for the 2027-05-20 effective date.
Timeline of related official records
Related official records are linked only when names and instrument numbers match exactly, so this timeline may be incomplete. Dates are as stated by the official sources. It is a monitoring aid, not legal advice; the original Japanese sources are authoritative.
- 2026-09-30 — Promulgated (instrument recorded by e-Gov Law Search) Original Japanese source
- 2027-05-20 — Effective date stated by e-Gov Law Search Original Japanese source